Dermatological Therapeutics Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Dermatological Therapeutics Market accounted for US$ 30365 million in 2020 and is estimated to be US$ 71024 million by 2030 and is anticipated to register a CAGR of 8.90%.

Dermatology is a branch of medicine that focuses on the diagnosis, prevention, and treatment of skin, nail, and hair problems such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also called dermatologicals, are skin-care products that are used topically. These products are used to treat a variety of skin diseases as well as to prevent certain skin disorders. Dermatologicals are also used for everyday skin care to keep one's skin healthy. Some dermatologicals, on the other hand, are systemic preparations that are utilised in individuals who do not respond to topical treatments. Furthermore, these formulations are utilised to treat acne, dermatitis, and psoriasis, among other skin diseases. Many countries around the world have endured and continue to incur significant economic and healthcare burdens as a result of the high transmission rate of COVID-19. During the COVID-19 pandemic 2020, all healthcare-based companies' manufacturing units were affected, and transportation was severely impacted across all developed and emerging economies. Over the projected period, the dermatological market will also experience certain indirect and direct effects.

Growing prevalence of dermatological illnesses will drive the growth of the Market

Growing prevalence of dermatological illnesses, increased understanding of disease progression and aetiology, and an increase in the older population are some of the reasons driving market expansion. Furthermore, as the population ages, dermatological treatment is anticipated to attract increased emphasis. Because of factors such as changes in connective tissue, a decrease in the skin's firmness and elasticity, and a decrease in sebaceous gland secretions, the chance of having skin-related illnesses increases as people age. For instance, According to the United Nations' Globe Population Prospects 2019 report (2019), there were approximately 703 million persons aged 65 and up in the world in 2019. In 2050, the world's old population is expected to increase to 1.5 billion people. The proportion of people aged 65 and up in the global population climbed from 6% in 1990 to 9% in 2019. Skin disorders have had a significant impact on people's quality of life around the world, resulting in lost productivity at work and other places, as well as prejudice due to disfigurement. Changes in the skin could signal the presence of more significant skin illnesses that need to be treated. For instance, According to the World Allergy Organization's 2018 data sheet, atopic dermatitis affects 5-30 percent of children and 1-10 percent of adults worldwide.

Furthermore, due to activities such as collaborations, acquisitions, and new product releases in the country, the worldwide dermatological treatments market is expected to see a profitable growth opportunity. LEO Pharma, for example, acquired the acquisition of Bayer's prescription dermatology business in July 2019, bolstering its presence in the dermatology portfolio globally. Similarly, Bayer and Azitra Inc. established a joint development agreement in January 2020 to use Azitra's unique panel of Staphylococcus epidermidis strains to find possible candidates for the treatment of skin diseases.

Dermatological Therapeutics Market is segmented based on application, drug class and region.

On the basis of Application, the Global Dermatological Therapeutics Market is segmented into Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications. Based on Drug Class, the target market is segmented into Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes.

Regional Insights:

On region the Dermatological Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to lead the global market due to rising healthcare expenditures, rising awareness of skin problems, and the strong presence of pharmaceutical businesses, which are expected to fuel market expansion. Rising skin cancer awareness campaigns in the region are also helping to drive market expansion. Skin cancer is the most frequent cancer in the United States, according to the American Academy of Dermatology Association, and unprotected ultraviolet (UV) exposure is the most preventable risk factor for skin cancer. Skin Cancer Awareness Month will be held in 2021 during the COVID-19 pandemic, and the facts will be communicated to help and save lives in the fight against skin cancer in the United States.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Dermatological Therapeutics Market report based on application, drug class and region.

Dermatological Therapeutics Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the dermatological therapeutics market are AGI Dermatics, Allergan Inc, Amgen Inc, Chester Valley Pharmaceuticals Inc, Dermik Laboratories Inc, Eisai Inc., Ferndale Laboratories Inc., Genentech Inc., Medicis Pharmaceutical Corp, Onset Therapeutics, Prime Pharmaceuticals Corp, Schering-Plough Corp, Sinclair Pharmaceuticals, Skinmedica Inc., Summers Laboratories Inc, Valeant Pharmaceuticals International, and others.  Eli Lilly & Company struck a binding agreement to buy Dermira, a dermatological medicine developer, for USD 1.1 billion in cash in January 2020, expanding its portfolio with commercial and late-stage drugs.

• AGI Dermatics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Allergan Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Amgen Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Chester Valley Pharmaceuticals Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Dermik Laboratories Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eisai Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Ferndale Laboratories Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Medicis Pharmaceutical Corp
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Dermatological Therapeutics Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Application
     • Market Snippet, By Drug Class
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
   • Overview                                                     
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Alopecia
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Herpes
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Psoriasis
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Rosacea
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Atopic Dermatitis
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Market Segmentation, By Drug Class, 2020 – 2030, (US$ Mn)
   • Overview                                                            
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Anti-Infectives
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Corticosteroids
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Anti-Acne
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Calcineurin Inhibitors
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Retinoids
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
7. Global Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Drug Class, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
8. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
9. Company Profiles

• AGI Dermatics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Allergan Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Amgen Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Chester Valley Pharmaceuticals Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Dermik Laboratories Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eisai Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Ferndale Laboratories Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Medicis Pharmaceutical Corp
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact